Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Mitesh Thacker of miteshthacker.com recommends selling Glenmark Pharma and advises avoiding Zee Entertainment.
Ruchit Jain of Angel Broking is of the view that one may buy Siemens with a target of Rs 1170.
Shahina Mukadam of Equityrush is of the view that one may buy State Bank of India (SBI) with a target of Rs 268.
According to Mitesh Thacker of miteshthacker.com, one can buy GSFC and Petronet LNG and sell Glenmark Pharma.
Ashwani Gujral of ashwanigujral.com advises buying HDFC and suggests selling Glenmark Pharma.
Mitesh Thacker of miteshthacker.com recommends buying Tech Mahindra and Corporation Bank and sell Glenmark Pharma, HDFC Bank and Karnataka Bank.
Ashwani Gujral of ashwanigujral.com recommends selling Glenmark Pharma, LIC Housing Finance and JSW Steel.
According to Amit Gupta of ICICIdirect, one can buy Castrol India and short LIC Housing Finance and Biocon.
Gaurav Ratnaparkhi of Sharekhan is of the view that one may sell Bajaj Finance with a target of Rs 1015.
In an interview with CNBC-TV18, market expert SP Tulsian gave his stock picks for the day and shared his market outlook.
Mitesh Thacker of miteshthacker.com recommends buying Glenmark Pharma and sell Bajaj Finance.
Good cash flows from the launch of cholesterol-lowering drug Zetia in December could help Glenmark Pharma trim its debt significantly by the end of the year says Pharma Analyst Surajit Pal of Prabhudas Lilladher. Glenmark will enjoy 134 days of exclusivity from the launch of the drug.
Mitesh Thacker of miteshthacker.com is of the view that one can buy Glenmark Pharma, Greenply, Cadila Healthcare and Vedanta.
Ashwani Gujral of ashwanigujral.com recommends buying Maruti Suzuki, ICICI Bank, Arvind, Glenmark Pharma and Tata Communications and advises selling ONGC.
Sudarshan Sukhani of s2analytics.com recommends buying Glenmark Pharma and Apollo Hospitals.
In an interview to CNBC-TV18 SP Tulsian of sptulsian.com shares his take on companies that declared their quarterly earnings like Strides Shasun and its peers, Kansai Nerolac and Colgate among others. He also shares his outlook on Eicher Motors.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Bajaj Finance, Dr Reddy's Laboratories and Aditya Birla Nuvo.
Sameet Chavan of Angel Broking recommends buying Just Dial with a target of Rs 492 and sell Glenmark Pharma with a target of Rs 860.
Credit Suisse maintains neutral rating on Glenmark due to high profit concentration in Mupirocin as upside risk exists from out-licensing opportunity from innovative R&D pipeline. Mupirocin cream accounts for 18 percent of FY18 EPS, as risk of competition is high.
Here are analysts' views on 11 stocks. Citi says Aurobindo Pharma remains India's top pharma pick as Teva business passes by and key overhang is lifted. It expects focus to shift back to company's robust fundamentals.
Sudarshan Sukhani of s2analytics.com advises buying LIC Housing Finance.
Amit Gupta of ICICI Direct is of the view that one may should remain long in the Glenmark Pharma as it may move to Rs 980-1020.
In an interview to CNBC-TV18, Prakash Diwan of Altamount Capital Management shared his readings and outlook on specific stocks and sectors.
VK Sharma of HDFC Securities is of the view that one may buy Glenmark Pharma 940 Call and sell 960 Call.
According to Mitesh Thacker of miteshthacker.com, one can buy Glenmark Pharma and DHFL.